These poems were among the work that made up my MFA thesis entitled “Flying on the Edge.” The thesis (which passed with no edits) combined poems of my successful battle with stage 4 Hodgkin lymphoma ...

HOUSTON – Hours before kickoff Sunday against the Buffalo Bills, Stacey Horton and Ron Horton couldn’t stop smiling. The parents were busting with pride after driving to Houston from Frisco to watch ...

HOUSTON – Texans defensive end Dylan Horton, in remission from Stage 4 Hodgkin’s Lymphoma after being diagnosed last season as a rookie, completed his final treatment and celebrated by ringing the ...

WICHITA, Kan. (KSNW) — Former Nickerson basketball star Ava Jones is speaking out about her cancer diagnosis months after a man was sentenced to seven decades in prison for the murder of her father in ...

Govind Sandhu says he feels “lucky” while documenting his diagnosis — and his treatment — for non-Hodgkin’s lymphoma Govind Sandhu/Instagram A TikTok music executive, 38, shared that he was diagnosed ...

Houston Texans defensive end Dylan Horton is officially cancer-free. Horton, who was diagnosed in December with Stage 4 Hodgkin lymphoma, shared a video on his Instagram of him ringing the bell after ...

NORTHBRIDGE — At Plummer Park Skate Park in Whitinsville on Thursday, 17-year-old Nate Isaacs, who was diagnosed with stage IV Hodgkin lymphoma last year, from Arlington gets pointers on mural ...

A Canadian woman with stage 4 cancer says she ignored signs of the disease because she believed them to be “eczema-related.” Taylor Deanne Roy, 32, experienced extreme tiredness and itchy skin for ...

Lend A Hand Up is a 501c3 nonprofit subsidiary of Dakota Medical Foundation supporting area families experiencing hardship due to a health issue, recent loss of life, or traumatic event. All funds ...

Stanford 4-Star DL Benedict Umeh makes return after Hodgkin lymphoma battles Benedict Umeh was Stanford's top-ranked defensive commitment in the 2024 class. Battles with Stage IV Hodgkin Lymphoma kept ...

In December 2025, the FDA accepted for priority review the supplemental biologics license application for nivolumab-AVD for the treatment of adult and pediatric patients 12 years and older with ...